Related Clinical Services

Rheumatology Program Research and Innovation

As one of the largest programs of its kind in the world, the Rheumatology Program at Boston Children’s Hospital is actively involved in studies that are improving the way children with inflammatory diseases are treated.

The following clinicians at Boston Children’s are conducting the most current research projects related to immunological disorders:

Robert C. Fuhlbrigge, MD, PhD, studies the development of immune memory and the mechanisms regulating leukocyte homing, or how immune cells find their way from the blood to tissues.

Peter Nigrovic, MD studies how arthritis begins. His laboratory investigates the role of antibodies and immune cells in triggering inflammation within joints, looking for new opportunities to intervene in order to improve treatment.

Robert Sundel, MD studies novel therapies for pediatric inflammatory disorders, especially vasculitis and arthritis. In addition, he is working on methods for improving the quality of care of children with rheumatologic disorders, and ways to better educate student doctors to care for these children.

“

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”